Mid-Size Pharmaceutical Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Prescription, Over the Counter); Application (Hospital, Clinics, Drug Store, E- Commerce, Others) and Geography

Report Code: TIPRE00018321 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET INTRODUCTION

Mid-Size Pharmaceutical is among the three categories of pharmaceutical industry. The global pharmaceutical industry is segmented on the basis of their revenue, therapy area, R&D expenditure, reach etc. The mid-sized pharmaceutical companies are those companies which have their revenue in range of US$ 1 billion to US$ 10 billion. Mid-size pharmaceutical emphasize on generic drug development and development of rare disease therapies.

MARKET DYNAMICS

The key market drivers for Mid-Size Pharmaceutical Market Includes, rising geriatric population across the globe along with increased prevalence of chronic disorders. Moreover, increased urbanization, increased government expenditures on healthcare sector are also expected to fuel market growth. Additionally, need for development of novel therapies is also expected to drive market growth during forecast period.

MARKET SCOPE

The "Mid-Size Pharmaceutical Market" is a specialized and in-depth study of the Pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of Mid-Size Pharmaceutical market with detailed market segmentation by type, application. The Mid-Size Pharmaceutical Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Mid-Size Pharmaceutical Market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Mid-Size Pharmaceutical Market is segmented on the basis of type and application. On the basis of type the market is segmented as, prescription drugs and OTC drugs. And on the basis of application the market is segmented as, hospital, clinics, drug store, E- commerce.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Mid-Size Pharmaceutical Market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Mid-Size Pharmaceutical Market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Mid-Size Pharmaceutical Market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Mid-Size Pharmaceutical Market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Mid-Size Pharmaceutical Markets organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Mid-Size Pharmaceutical Market are anticipated to have lucrative growth opportunities in the future with the rising demand for, Mid-Size Pharmaceutical market in the global market. Below mentioned is the list of few companies engaged in the Mid-Size Pharmaceutical Market.

The report also includes the profiles of key players in Mid-Size Pharmaceutical Market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •   Daiichi Sankyo
  •   Valeant Pharmaceuticals
  •   Eisai
  •   Regeneron Pharmaceuticals
  •   UCB
  •   Les Laboratories Servier
  •   Sun Pharmaceutical
  •   Endo International
  •   Mallinckrodt
  •   Alexion Pharmaceuticals

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Mid-Size Pharmaceutical Market - By Type
1.3.2 Mid-Size Pharmaceutical Market - By Application
1.3.3 Mid-Size Pharmaceutical Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. MID-SIZE PHARMACEUTICAL MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. MID-SIZE PHARMACEUTICAL MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. MID-SIZE PHARMACEUTICAL MARKET - GLOBAL MARKET ANALYSIS
6.1. MID-SIZE PHARMACEUTICAL - GLOBAL MARKET OVERVIEW
6.2. MID-SIZE PHARMACEUTICAL - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. MID-SIZE PHARMACEUTICAL MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. PRESCRIPTION
7.3.1. Overview
7.3.2. Prescription Market Forecast and Analysis
7.4. OVER THE COUNTER
7.4.1. Overview
7.4.2. Over the Counter Market Forecast and Analysis
8. MID-SIZE PHARMACEUTICAL MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL
8.3.1. Overview
8.3.2. Hospital Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
8.5. DRUG STORE
8.5.1. Overview
8.5.2. Drug Store Market Forecast and Analysis
8.6. E- COMMERCE
8.6.1. Overview
8.6.2. E- Commerce Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis

9. MID-SIZE PHARMACEUTICAL MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Mid-Size Pharmaceutical Market Overview
9.1.2 North America Mid-Size Pharmaceutical Market Forecasts and Analysis
9.1.3 North America Mid-Size Pharmaceutical Market Forecasts and Analysis - By Type
9.1.4 North America Mid-Size Pharmaceutical Market Forecasts and Analysis - By Application
9.1.5 North America Mid-Size Pharmaceutical Market Forecasts and Analysis - By Countries
9.1.5.1 United States Mid-Size Pharmaceutical Market
9.1.5.1.1 United States Mid-Size Pharmaceutical Market by Type
9.1.5.1.2 United States Mid-Size Pharmaceutical Market by Application
9.1.5.2 Canada Mid-Size Pharmaceutical Market
9.1.5.2.1 Canada Mid-Size Pharmaceutical Market by Type
9.1.5.2.2 Canada Mid-Size Pharmaceutical Market by Application
9.1.5.3 Mexico Mid-Size Pharmaceutical Market
9.1.5.3.1 Mexico Mid-Size Pharmaceutical Market by Type
9.1.5.3.2 Mexico Mid-Size Pharmaceutical Market by Application
9.2. EUROPE
9.2.1 Europe Mid-Size Pharmaceutical Market Overview
9.2.2 Europe Mid-Size Pharmaceutical Market Forecasts and Analysis
9.2.3 Europe Mid-Size Pharmaceutical Market Forecasts and Analysis - By Type
9.2.4 Europe Mid-Size Pharmaceutical Market Forecasts and Analysis - By Application
9.2.5 Europe Mid-Size Pharmaceutical Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Mid-Size Pharmaceutical Market
9.2.5.1.1 Germany Mid-Size Pharmaceutical Market by Type
9.2.5.1.2 Germany Mid-Size Pharmaceutical Market by Application
9.2.5.2 France Mid-Size Pharmaceutical Market
9.2.5.2.1 France Mid-Size Pharmaceutical Market by Type
9.2.5.2.2 France Mid-Size Pharmaceutical Market by Application
9.2.5.3 Italy Mid-Size Pharmaceutical Market
9.2.5.3.1 Italy Mid-Size Pharmaceutical Market by Type
9.2.5.3.2 Italy Mid-Size Pharmaceutical Market by Application
9.2.5.4 Spain Mid-Size Pharmaceutical Market
9.2.5.4.1 Spain Mid-Size Pharmaceutical Market by Type
9.2.5.4.2 Spain Mid-Size Pharmaceutical Market by Application
9.2.5.5 United Kingdom Mid-Size Pharmaceutical Market
9.2.5.5.1 United Kingdom Mid-Size Pharmaceutical Market by Type
9.2.5.5.2 United Kingdom Mid-Size Pharmaceutical Market by Application
9.2.5.6 Rest of Europe Mid-Size Pharmaceutical Market
9.2.5.6.1 Rest of Europe Mid-Size Pharmaceutical Market by Type
9.2.5.6.2 Rest of Europe Mid-Size Pharmaceutical Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Mid-Size Pharmaceutical Market Overview
9.3.2 Asia-Pacific Mid-Size Pharmaceutical Market Forecasts and Analysis
9.3.3 Asia-Pacific Mid-Size Pharmaceutical Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Mid-Size Pharmaceutical Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Mid-Size Pharmaceutical Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Mid-Size Pharmaceutical Market
9.3.5.1.1 Australia Mid-Size Pharmaceutical Market by Type
9.3.5.1.2 Australia Mid-Size Pharmaceutical Market by Application
9.3.5.2 China Mid-Size Pharmaceutical Market
9.3.5.2.1 China Mid-Size Pharmaceutical Market by Type
9.3.5.2.2 China Mid-Size Pharmaceutical Market by Application
9.3.5.3 India Mid-Size Pharmaceutical Market
9.3.5.3.1 India Mid-Size Pharmaceutical Market by Type
9.3.5.3.2 India Mid-Size Pharmaceutical Market by Application
9.3.5.4 Japan Mid-Size Pharmaceutical Market
9.3.5.4.1 Japan Mid-Size Pharmaceutical Market by Type
9.3.5.4.2 Japan Mid-Size Pharmaceutical Market by Application
9.3.5.5 South Korea Mid-Size Pharmaceutical Market
9.3.5.5.1 South Korea Mid-Size Pharmaceutical Market by Type
9.3.5.5.2 South Korea Mid-Size Pharmaceutical Market by Application
9.3.5.6 Rest of Asia-Pacific Mid-Size Pharmaceutical Market
9.3.5.6.1 Rest of Asia-Pacific Mid-Size Pharmaceutical Market by Type
9.3.5.6.2 Rest of Asia-Pacific Mid-Size Pharmaceutical Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Mid-Size Pharmaceutical Market Overview
9.4.2 Middle East and Africa Mid-Size Pharmaceutical Market Forecasts and Analysis
9.4.3 Middle East and Africa Mid-Size Pharmaceutical Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Mid-Size Pharmaceutical Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Mid-Size Pharmaceutical Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Mid-Size Pharmaceutical Market
9.4.5.1.1 South Africa Mid-Size Pharmaceutical Market by Type
9.4.5.1.2 South Africa Mid-Size Pharmaceutical Market by Application
9.4.5.2 Saudi Arabia Mid-Size Pharmaceutical Market
9.4.5.2.1 Saudi Arabia Mid-Size Pharmaceutical Market by Type
9.4.5.2.2 Saudi Arabia Mid-Size Pharmaceutical Market by Application
9.4.5.3 U.A.E Mid-Size Pharmaceutical Market
9.4.5.3.1 U.A.E Mid-Size Pharmaceutical Market by Type
9.4.5.3.2 U.A.E Mid-Size Pharmaceutical Market by Application
9.4.5.4 Rest of Middle East and Africa Mid-Size Pharmaceutical Market
9.4.5.4.1 Rest of Middle East and Africa Mid-Size Pharmaceutical Market by Type
9.4.5.4.2 Rest of Middle East and Africa Mid-Size Pharmaceutical Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Mid-Size Pharmaceutical Market Overview
9.5.2 South and Central America Mid-Size Pharmaceutical Market Forecasts and Analysis
9.5.3 South and Central America Mid-Size Pharmaceutical Market Forecasts and Analysis - By Type
9.5.4 South and Central America Mid-Size Pharmaceutical Market Forecasts and Analysis - By Application
9.5.5 South and Central America Mid-Size Pharmaceutical Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Mid-Size Pharmaceutical Market
9.5.5.1.1 Brazil Mid-Size Pharmaceutical Market by Type
9.5.5.1.2 Brazil Mid-Size Pharmaceutical Market by Application
9.5.5.2 Argentina Mid-Size Pharmaceutical Market
9.5.5.2.1 Argentina Mid-Size Pharmaceutical Market by Type
9.5.5.2.2 Argentina Mid-Size Pharmaceutical Market by Application
9.5.5.3 Rest of South and Central America Mid-Size Pharmaceutical Market
9.5.5.3.1 Rest of South and Central America Mid-Size Pharmaceutical Market by Type
9.5.5.3.2 Rest of South and Central America Mid-Size Pharmaceutical Market by Application

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. MID-SIZE PHARMACEUTICAL MARKET, KEY COMPANY PROFILES
11.1. DAIICHI SANKYO
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. VALEANT PHARMACEUTICALS
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. EISAI
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. REGENERON PHARMACEUTICALS
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. UCB
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. LES LABORATORIES SERVIER
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. SUN PHARMACEUTICAL
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. ENDO INTERNATIONAL
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. MALLINCKRODT
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. ALEXION PHARMACEUTICALS
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Daiichi Sankyo
2. Valeant Pharmaceuticals
3. Eisai
4. Regeneron Pharmaceuticals
5. UCB
6. Les Laboratories Servier
7. Sun Pharmaceutical
8. Endo International
9. Mallinckrodt
10. Alexion Pharmaceuticals
TIPRE00018321
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking